[1]
“The Prevalence Of Pulmonary And Cutaneous Manifestations In Connective Tissue Diseases: A Cross-Sectional Study”, Journal of Pharmaceutical Negative Results, pp. 3899–3902, May 2023, doi: 10.47750/pnr.2023.14.03.488.